ArticleMycobiology2022
Biological Control of Oomycete Soilborne Diseases Caused by
Article in Mycobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.
- Meta-analysis of corm yield responses to chemical and biological approaches for managing taro leaf blight disease.Pest management science · 2026Pooled it
- Article
- Multifunctional Roles of Bacillus spp. in Sustainable Agriculture: Advances in Biocontrol, Omics, and Ecological Applications.Microbial ecology · 2026Review
- Molecular Interactions Between Soil-Borne Oomycetes and Plants: Infection Mechanisms, Host Resistance, and Implications for Sustainable Agriculture.Plants (Basel, Switzerland) · 2026Review
- Unlocking olive rhizobacteria: harnessing biocontrol power to combat olive root rot and promote plant growth.International microbiology : the official journal of the Spanish Society for Microbiology · 2025Article
- Deciphering the Molecular Interplay Between RXLR-EncodedInternational journal of molecular sciences · 2025Review
- Biocontrol Effect ofMicroorganisms · 2025Article
- Revealing microbial consortia that interfere with grapevine downy mildew through microbiome epidemiology.Environmental microbiome · 2025Article
- The relationship between pomegranate root collar rot and the diversity of fungal communities in its rhizosphere.Frontiers in microbiology · 2025Article
- An Improved Sporulation Method for Producing Asexual Zoospores ofMycobiology · 2025Article
- Antagonistic Effects and Volatile Organic Compound Profiles of Rhizobacteria in the Biocontrol ofPlants (Basel, Switzerland) · 2024Article
- Proclaiming Plant Growth-Promoting and Antifungal Properties of Pseudomonas lurida and Bacillus velezensis Isolated from Rhododendrons of Darjeeling Hills.Current microbiology · 2024Article
- Managing tobacco black shank disease using biochar: direct toxicity and indirect ecological mechanisms.Microbiology spectrum · 2024Article
- Deciphering fungicide resistance in Phytophthora: mechanisms, prevalence, and sustainable management approaches.World journal of microbiology & biotechnology · 2024Review
- The Effects of Antofine on the Morphological and Physiological Characteristics ofMolecules (Basel, Switzerland) · 2024Article
- A comprehensive review of integrated management strategies for damping-off disease in chili.Frontiers in microbiology · 2024Review
- Biocontrol of Diseases Caused byJournal of fungi (Basel, Switzerland) · 2023Article
- Anti-Oomycete Activity and Pepper Root Colonization of Pseudomonas plecoglossicida YJR13 and Pseudomonas putida YJR92 against Phytophthora capsici.The plant pathology journal · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oomycete pathogens that belong to the genus
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.